| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040304525 |
| P356 | DOI | 10.1038/SJ.ONC.1202696 |
| P698 | PubMed publication ID | 10380885 |
| P5875 | ResearchGate publication ID | 12918075 |
| P2093 | author name string | Liu C | |
| Fan Y | |||
| Adamson ED | |||
| Huang RP | |||
| Mercola D | |||
| de Belle I | |||
| P2860 | cites work | X-linked IAP is a direct inhibitor of cell-death proteases | Q24318710 |
| Disruption of epithelial cell-matrix interactions induces apoptosis | Q24673611 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Cleavage of focal adhesion kinase by caspases during apoptosis | Q28610850 | ||
| Suppression of human colorectal carcinoma cell growth by wild-type p53 | Q29618318 | ||
| A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization | Q29618351 | ||
| Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain | Q29620169 | ||
| Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase | Q30442141 | ||
| Inhibition of pp125FAK in cultured fibroblasts results in apoptosis | Q30442183 | ||
| Control of adhesion-dependent cell survival by focal adhesion kinase | Q30442196 | ||
| The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression | Q34197959 | ||
| p53 functions as a cell cycle control protein in osteosarcomas | Q34254691 | ||
| E1a induces the expression of epithelial characteristics | Q36382960 | ||
| Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. | Q36555870 | ||
| Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. | Q37271247 | ||
| The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage | Q38322297 | ||
| The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. | Q38328584 | ||
| Role of Egr-1 gene expression in B cell receptor-induced apoptosis in an immature B cell lymphoma | Q38342103 | ||
| EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells | Q38351455 | ||
| Modifications of p53 Protein and Accumulation of p21 and gadd45 mRNA in TGF-β1 Growth Inhibited Cells | Q38557138 | ||
| Radiation induction of immediate early genes: effectors of the radiation-stress response. | Q40701268 | ||
| Tumor-suppressor p53 and the cell cycle | Q40886481 | ||
| Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation | Q40961191 | ||
| Reversal of malignancy by the adenovirus E1a gene | Q41002704 | ||
| SAGE transcript profiles for p53-dependent growth regulation | Q41092725 | ||
| Early growth response-1-dependent apoptosis is mediated by p53. | Q41094563 | ||
| Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene. | Q41101036 | ||
| Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism | Q41131825 | ||
| C-jun and Egr-1 participate in DNA synthesis and cell survival in response to ionizing radiation exposure | Q41258141 | ||
| Essential role for p53-mediated transcription in E1A-induced apoptosis | Q41302308 | ||
| Functions of the p53 Protein in Growth Regulation and Tumor Suppression | Q41506167 | ||
| UV activates growth factor receptors via reactive oxygen intermediates | Q42772075 | ||
| Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells | Q42811974 | ||
| V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras | Q42832188 | ||
| Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells | Q45125758 | ||
| Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. | Q47827995 | ||
| Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells. | Q55006218 | ||
| Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation | Q73486628 | ||
| Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1 | Q73959969 | ||
| Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2 | Q77132887 | ||
| Caspase 3 specifically cleaves p21WAF1/CIP1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells | Q77500551 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3633-3642 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis | |
| P478 | volume | 18 |
| Q40228726 | A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells |
| Q35631310 | A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma |
| Q39832548 | ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line |
| Q24791660 | Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques |
| Q44820578 | Chronic beta-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart |
| Q39984972 | Early growth response-1 mediates downregulation of telomerase in cervical cancer |
| Q39291837 | Egr-1 promotes cell proliferation and invasion by increasing β-catenin expression in gastric cancer |
| Q36397206 | Experimental and clinicopathologic study on the relationship between transcription factor Egr-1 and esophageal carcinoma |
| Q37288653 | Expression of early growth response gene-1 in precancerous lesions of gastric cancer |
| Q35124631 | Expression of p53 target genes in the early phase of long-term potentiation in the rat hippocampal CA1 area |
| Q36956729 | Focal adhesion kinase: a promising target for anticancer therapy |
| Q34202111 | Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures |
| Q33930977 | Gene program for cardiac cell survival induced by transient ischemia in conscious pigs |
| Q33939860 | High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. |
| Q28474350 | Identification of G1-regulated genes in normally cycling human cells |
| Q64107528 | Identification, Characterization, and Regulatory Mechanisms of a Novel EGR1 Splicing Isoform |
| Q30884647 | In vivo cloning and characterization of a new growth suppressor protein TOE1 as a direct target gene of Egr1. |
| Q38297130 | Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2. |
| Q38315535 | Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1. |
| Q35614417 | Iron deficiency upregulates Egr1 expression |
| Q34771610 | Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses |
| Q35208830 | MAPK pathways in radiation responses |
| Q37748135 | Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms |
| Q49426279 | MicroRNA expression and activity in T-cell acute lymphoblastic leukemia |
| Q47318797 | Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1. |
| Q36084467 | Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy |
| Q24321834 | PTEN regulation by Akt-EGR1-ARF-PTEN axis |
| Q36247578 | Radiation Induced Apoptosis of Murine Bone Marrow Cells Is Independent of Early Growth Response 1 (EGR1). |
| Q36059868 | Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis |
| Q34468320 | Suppression of Egr-1 transcription through targeting of the serum response factor by oncogenic H-Ras |
| Q33809324 | Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1. |
| Q34107166 | T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells |
| Q93116743 | TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells |
| Q24337568 | TOE1 interacts with p53 to modulate its transactivation potential |
| Q43848062 | The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling |
| Q35844124 | The expression of B23 and EGR1 proteins is functionally linked in tumor cells under stress conditions. |
| Q77368785 | The expression of genes induced in melanocytes by exposure to 365-nm UVA: study by cDNA arrays and real-time quantitative RT-PCR |
| Q33920222 | The human transcriptional repressor protein NAB1: expression and biological activity |
| Q40883612 | The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251. |
| Q35161251 | The transcription factor EGR1 localizes to the nucleolus and is linked to suppression of ribosomal precursor synthesis |
| Q36247095 | The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. |
| Q36316031 | Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines |
| Q38361499 | Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway |